- Main
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
- Avutu, Viswatej;
- Weiss, Aaron R;
- Reed, Damon R;
- Ahmed, Safia K;
- Allen-Rhoades, Wendy A;
- Chen, Yen-Lin E;
- Davis, Lara E;
- Eaton, Bree R;
- Hawkins, Douglas S;
- Indelicato, Danny J;
- Patel, Shreyaskumar R;
- Randall, R Lor;
- Reinke, Denise K;
- Riedel, Richard F;
- Scharschmidt, Thomas J;
- Thornton, Katherine A;
- Wang, Dian;
- Janeway, Katherine A;
- Kopp, Lisa M
- et al.
Published Web Location
https://doi.org/10.1089/jayao.2021.0103Abstract
ARST1321, a trial of patients with advanced soft tissue sarcoma, was the first National Clinical Trials Network study codeveloped by pediatric and adult consortia with two treatment cohorts. We report on the findings of a survey to identify barriers to enrolling adolescent and young adult patients (15-39 years) onto the nonchemotherapy arm. The survey response rate was 31% with a 70% completion rate. Common identified reasons for low accrual in order of decreasing frequency included insufficient funding, lack of study awareness or interest, competing trials, toxicity concerns, philosophical differences in the therapy backbone, and regulatory and infrastructure barriers. Clinical Trials.gov ID: NCT02180867.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-